ison of vildagliptin and metformin mon-otherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, ran- domized trial. Diabetes Obes Metab 2009;11:804 –812 23. Goldstein BJ, Feinglos MN, Lunceford JK, Johnson J, Williams-Herman DE; Sitagliptin 036 Study Group. Effect of initial combi-nation therapy with sitagliptin, a dipeptidylpeptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes. Diabetes Care 2007;30:1979 – 1987 24. DeFronzo RA, Goodman AM; The Mul- ticenter Metformin Study Group. Ef ﬁ- cacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333:541 –549 25. Bunck MC, Cornér A, Eliasson B, et al. Effects of exenatide on measures ofb-cell function after 3 years in metformin- treated patients with type 2 diabetes. Di- abetes Care 2011;34:2041 –2047